REGN LONG prediction · ibdlive · Bullseye
I'm looking at a lot of flat bases, Vertex, Amgen, Regeneron, you know, a few of these big biomed biotech companies have made these patterns. And they're breaking out, holding up the relative strength line is up there.
- Channel
- ibdlive
- Prediction date
- 2023-10-16
- Horizon
- 2024-10-16
- Instrument
- REGN · LONG
- Verdict
- Bullseye
- Outcome
- <strong>Bullseye:</strong> Entry $836.75 → Exit $999.70 · <span class="num green">P/L +19.5%</span> · <span class="num red">vs SPY -15.9%</span>
Source: Source · 00:41 ↗